India allows Serum Institute to enrol 7-11 year olds in Covid-19 vaccine trial

India's drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its Covid-19 vaccine trial as the country prepares to protect children from the coronavirus. Serum Institute is already conducting a trial of its Covid-19 vaccine in the 12-17 age group and has presented safety data for an initial 100 participants.